Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07158918 |
| Title | ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | ABL Bio, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UH Cleveland Medical Center | NOT_YET_RECRUITING | Cleveland | Ohio | 44106 | United States | Details |
| PASO Medical | NOT_YET_RECRUITING | Frankston | Victoria | 3199 | Australia | Details |
| Seoul National University Bundang Hospital | RECRUITING | Seongnam | 13620 | South Korea | Details | |
| Seoul National University Hospital | RECRUITING | Seoul | 03080 | South Korea | Details | |
| Asan Medical Center | NOT_YET_RECRUITING | Seoul | 05505 | South Korea | Details | |
| Samsung Medical Center | NOT_YET_RECRUITING | Seoul | 06351 | South Korea | Details |